medic technolog devic
stay loop monthli diabet newslett investor may
recess due
today launch new recur seri note call stay loop
proprietari diabetes-focus newslett releas monthli basi
note look exclus diabet space serv great resourc
investor navig sector note includ focu topic month
given current environ today month focu topic specif
look implic diabet commun action taken assist
patient unpreced time addit document look rel
valuat applic news item month clinic trial updat reimburs
regulatori landscap prescript data on-going trend diabet commun
proprietari catalyst calendar insulin pump smart pen
could potenti catalyst expedit cgm use hospit
result sever impact viru diabet patient popul fda
health canada temporarili author cgm use treat hospit
patient noth certain consider amount data collect
process could help expedit fda approv process perman cgm use
hospit plan work futur base rough
math commentari analyst day think longer-
term opportun could alon
ypsome dexcom partnership announc someth monitor monday
morn ypsome switzerland base insulin pump manufactur uncov
announc form partnership develop hybrid close loop
ypsopump integr expect final end earli
europ patient upgrad via app updat overal feel
offici announc expect mani trend investor monitor
given desir build open-platform agnost insulin pump manufactur
simpli put partner integr think patient choos
best aid technolog avail believ tandem control iq right
caus delay product introduct heard
dexcom tandem earn call may impact clinic
trials/new product introduct current factor month delay
pivot trial tandem expect impact compani test
certain product submiss mobil bolus sport hope find
inform potenti horizon delay insulet earn call week
proprietari catalyst calendar insulin pump smart pen help
investor monitor on-going upcom trend diabet sector
creat proprietari catalyst calendar insulin pump smart pen
calendar updat time includ compani outsid
coverag univers addit includ privat compani may becom
signific competit entrant next year
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
ii focu implic diabet
news regulatory/reimburs
page
current look diabet sector happen
valuat compar broader landscap
page
ytd share price perform diabet compani etf
year ev/ ntm sale diabet compani vs sector
factset share price data valuat multipl
psc take first glanc diabet sector
consider expens space
two year averag believ premium valuat
warrant howev like
result attract end-market
compar diabet space basket
high-growth name top-lin basi
interest see ev/sal premium vs
vs broader industri think
make valuat space palat
especi consid long-term outlook
page
implic diabet
happen right across space assist
diabet patient pandem
page
action reduc financi burden patient
even cost diabet enabl technolog suppli forefront consum mind financi
uncertainti percol across countri peopl lose job take pay cut reduc work hour etc outlin
announc coverag univers help reduc burden place famili individu may continu current
announc april expand financi assist program individu impact
certain individu qualifi program meet specif set financi criteria may provid six-month
suppli product free charg note suppli pod program primarili focus custom lost
job and/or insur cover medicaid insur result viru program avail decemb
psc take saw week ago lilli novo nordisk insulin price cap announc effort made
across industri reliev financi burden diabet patient impact solut may
temporari think help certain famili bridg gap thing normal financi addit think collect
effort devic manufactur pharmaceut corpor import ensur impact address properli
util perspect mindset patient look cut discretionari expens elsewher everyth possibl
stay insulin pumps/cgm given improv devic provid manag blood glucos level
announc april start new patient assist program current custom meet specif
criteria program expect launch next sever week avail custom elig program
plan provid two shipment cgm suppli reduc cost compar insur
includ co-pay out-of-pocket program aim assist peopl lost insur coverag result covid-
pandem elig state feder program
psc take would surpris alreadi start lose patient unemploy rate around
world increas dramat due viru shelter-in-plac rule consequ believ program prudent keep
patient engag cgm critic point also opinion program compassion decis well feel
diabet commun appreci rememb assist unpreced time strong balanc sheet
cash posit financi mean employ strategi believ pay futur keep patient
cgm strengthen custom loyalti brand
page
cgm use hospit set diabet patient
impact human life devast patient diabet viru specif overwhelm increas
hospit rate accord cdc peopl diagnos diabet also contract
hospit patient diabet sent hospit without cgm situat frighten busi staff may abl
administ minut finger stick check in normal cadenc offici cgm approv hospit set fda
temporarili allow use pandem assist abbott uncov announc plans/don
help patient provid alik
april announc author fda use cgm hospit set assist hospit
system manufactur sensor donat phone receiv kevin sayer ceo
diabet connect podcast week ago talk announc sensor cost less charg
commerci patient make financi burden low possibl far anecdot feedback posit work
simplifi train guid staff page quick starter video on-demand
similar fashion abbott announc freestyl libr use hospit set associ american
diabet associ ada insulin life usa diabet disast respons coalit abbott donat sensor hospit
system across countri
psc take believ fda decis temporarili allow cgm usag hospit set outbreak sensibl
end applaud effort made abbott provid hospit suffici suppli sensor
earn call mr sayer talk excit prospect widespread use cgm hospit set given
fda yet approv cgm hospit talk wealth real-world data compani fda abl review
look viru long behind us posit abbott view
addit health canada temporarili allow use hospit set monitor patient impact
april abbott announc compani donat freestyl libr sensor ensur hospit adequ suppli
interest abbott releas quot inform health canada canadian diagnos hospit
may also announc receiv temporari author expand use hospit treat
patient hospit contract
center diseas control diabet connect podcast stacey simm listen appl podcast app health canada
page
cgm use hospit set diabet patient
psc estim hospit long-term opportun
psc take shown size opportun sizeabl time
tell eventu util think along non-
intens directli prove better health
outcom reduc healthcar expens believ
appetit amongst stakehold use technolog plan
work topic later point want walk
think high level
consider base inform investor day
pre-admiss approxim diabet patient admit hospit hyperglycemia prior elect surgic
procedur accord manag sometim even delay procedur caus ineffici system
inpati accord hn report inpati diabet popul experi hyperglycemia experi
hypoglycem event overal accord market research averag hypoglycem event increas cost hospit
post-discharg final accord diabet patient experienc sever hyper- hypoglycem event hospit
three time greater probabl patient readmit within base becker hospit review articl june
cost hospit re-admiss averag endocrine/metabol diseas
psc estim investor day materi truven market scan databas lilli healthcar util project hcup diabet hospit ramp inpati hn jun
updat inpati glycem control us hospit aac becker hospit review
page
million except aestim hospit market size penetr patient market dexcom hospit patient asp sensor revenu opportun news
top diabet news item clinic trial updat
page
top diabet news item month
may ypsome ypsn uncov announc partnership develop hybrid close loop system use
dexcom typezero algorithm cgm sensor current eventu compani plan incorpor blood glucos data
ypsome mylif app patient smartphon partnership allow ypsopump user share pump cgm data wirelessli
physician caregiv use mylif cloud product integr expect complet late earli europ patient
abl util new featur via updat app without upgrad hardwar
psc take prior offici announc believ investor expect formal partnership announc
point made clear continu partner sever insulin pump provid use
typezero algorithm build open-platform think partnership pump manufactur typezero someth
monitor believ patient gravit toward best aid technolog avail today believ tandem control iq
late april senseon hold uncov announc enter new senior secur loan agreement
highbridg capit manag accord term draw option matur date octob
interest accord releas financ provid necessari runway explor strateg altern announc late
march develop activ eversens xl cgm use
psc take overli surpris announc think implant cgm still valuabl today
market also posit given announc march halt commerci activ cgm addit
capit agreement posit space whole show opportun mani smaller compani rais
capit environ
premier april pb televis nationwid documentari call blood sugar rise america hidden diabet epidem follow
live sever diabet patient vari sever documentari focus rise diabet past year financi
burden diseas emerg technolog assist day day treatment type type diabet
psc take documentari necessarili devic focus burden cost diseas thought
alarm nugget spread diseas particip documentari believ half popul
diabet pre-diabet interest notion younger individu develop type diabet
complic aggress younger patient also close loop system appetit mani differ
system bespok model instead one option patient
page
earn call april updat investor statu clinic trial timelin due viru
psc take believ manag bit conserv given uncertainti moment would surpris see
trial start finish earlier commun
april adapt clinic trial updat activ recruit recruit purpos studi
evalu safeti efficaci ahcl system sub-optim control type patient use version compar mdi
cgm fgm trial enrol patient complet investig center europ
psc take nice see enrol complet trial common knowledg pivot trial investor
realli care right
page
pleas note pma data includ origin supplement file decis
pma includ supplement file overview applic updat
dexcom histor pma
updat april fda approv two
supplementari pma file abbott diabet
deal glucos sensor puck freestyl libr
day freestyl libr updat in-
process optic setup imag process vision
system verifi three critic qualiti attribut
 food drug pma databas
page
pleas note pma data includ origin supplement file decis
insulin pump regulatory/reimburs overview updat
pma includ supplement file overview applic updat
tandem histor pma
medtron diabet histor pma
updat april fda approv two supplementari pma file pump april process
chang allow circuit board assembl re-us construct refurbish pump
 food drug pma databas
pleas note pma data includ submiss decis insulin pump correspond cgm
page
bloomberg script data abbott
page
bloomberg weekli script data abbott
insulet omnipod omnipod dash
psc take fda author prescript option
patient ensur necessari suppli covid-
disrupt caus increas late march late
march peak weekli script level
blend averag today think structur
deterior temporari declin due front-load
suppli ahead shelter place guidelin potenti
less new patient start due peopl stuck home due
sip guidelin
page
overview recent trend discuss diabet social media
channel podcast
page
support phone line across industri longer normal
psc take ideal understand wait time may bit longer due unpreced natur overal
think thing get back normal next month problem get iron
hand post across facebook control iq user satisfact better blood sugar perform
psc take everi case differ start see peopl pleas blood sugar level
time rang hammer calibr intricaci involv algorithm
medtron insulin juicebox podcast type diabet scott benner
psc take kol join scott discuss experi use insulin view podcast provid real
world experi use product compar
loop hous part part juicebox podcast type diabet scott benner
psc take interest convers kol becom extrem well-vers do-it-yourself loop stood us
control detail calibr do-it-yourself loop offer patient parent control blood glucos level
make cgm system avail hospit need diabet connect stacey simm
psc take stacey convers ceo kevin sayer cgm system hospit set convers focus
train staff could happen diabet patient hospit without cgm intricaci
work interest see dynam evolv post
reddit diabet forum facebook control iq group juicebox podcast type diabet diabet connect podcast
page
catalyst calendar insulin pump smart pen
page
pleas note subject chang due potenti delay
may
compani file press releas transcript psc estim
pleas note timelin subject chang due
page
companyevent/catalystpsc estim pivot datasumm june ada expect present mini pivot commerci adult clinic data marchperson system fda breakthrough design tir goalcontrol-iq pediatricsbefor summer pediatr data fda sever week agobasal-iq franc germanycontrol-iq roll back half ace file dedic controllersumm push due ace file dedic control mobil appshortli summer filingpotenti push due mobil app controlsumm bit delay due announc callt sport beta thing could get delay wait safe travelt sport full commerci predict time may delay due covidcontrol iq algorithm updat pivot trialsometim exactli sure time expect someth pre-pivot data readoutexpect ada june lead investig present data horizon pivot trial primari data readoutlat glitch fix expect april week delayedhorizon commerci launchearli close loop system eventu libr integrationomnipod rolloutov cours enter market year latter half concentr call sidelin time focu cgm aid concentr call sidelin time focu cgm aid integrationbeta bionic insulin featurebeta bionic hormon insulin glucagon approv iletbeta bionic approvalevotim uncertaincam inc bandag like patch pump potenti dual hormonelilli aid work integr cgmypsom eu integrationl earli integr avail mylif app updateypsom approv submissionmid new approv pathway plan dana-i-pump fda diabeloop icontrol primari result octob patch roch unclearc mark juli roll later pointbecton dickinson patch time uncertain engag third parti clear timingbigfoot insulin pump integr freestyl libr diabeloop dblgi clinic trial on-going primari complet oct pleas note subject chang due potenti delay
may
compani file press releas transcript psc estim
pleas note timelin subject chang due
page
companyevent/catalystpsc estim timingnotes/commentarynext icgm fingerstick fda submiss icgm sensor post fda submiss calibr day wear japan reimburs spend requir time get adequ pivot trial beginsdelay delay minimum pivot trial data read-outdelay delay minimum commerci launchsometim later year due trial delay intern enter japan south korea later approv inpati hospit useunclearunclear time could speed uplibr fda icgm product work open item fda libr intern ou roll-out year benefit throughout yearlibr japan reimburs mdisreceiv spring calllibr commerci product work open item fda fda approv inpati hospit useunclearunclear time could speed upeversens xl cgm fda studi primari complet date march xl cgm eu studi europ useversens xl cgm fda march fda approv promis studi move daysmetronom commerci soft launch elit come readout elit ii ousmetronom fda anim on-going trial animalswaveform cgm cascad file fda launch free size nickel patent sensor array technologynemaura sugarbeatunclearc mark estim lower cost skin patch cgm submit fda juli eclips icgmunclearicgm worn skin year longer trial underwaysenseon dexcom abbott competitor pleas note subject chang due potenti delay
may
compani file press releas transcript psc estim
pleas note timelin subject chang due
page
companyevent/catalystpsc estim timingnotes/commentaryin fda clearanc fiaspfebruari februari fast act insulin usein fda clearanc fix dose meal estimationfebruari februari new bolu calculatornew version applicationapril april help fix dose meal estimationconnect pre-fil insulin regulatori reviewpartnership announc decemberultra-rapid lispro insulin approvalsometim japan europenovo compat cgm android iphonenovo compat cgm android iphonesanofi smart launchunclearin agreement partnership said avail next year septemb medic uniti fda target mdi user move pump laterafrezza inhal insulin bt connect sometim pediatr trial plan start wellypsom mylif smart approvalunclearcurr develop novo nordisk companion medic eli lilli competitor product rate price target risk
rate overweight pt base sale assum net cash fulli dilut
rate overweight pt base cy ep risk includ slowdown key market
rate overweight pt base ev/revenu assum net debt
share outstand risk includ regulatori establish competit global insulin deliveri market
rate overweight pt base sale assum net cash s/o
risk includ competit reimburs regulatori delay
page
